Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 42 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1983 adjusted for splits and dividends. The latest closing stock price for Amgen as of August 11, 2025 is 285.09.
  • The all-time high Amgen stock closing price was 329.11 on September 20, 2024.
  • The Amgen 52-week high stock price is 339.17, which is 19% above the current share price.
  • The Amgen 52-week low stock price is 253.30, which is 11.2% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 297.35.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 288.7509 254.9490 324.4920 254.2700 285.0900 11.24%
2024 293.2592 283.8460 329.1120 252.7440 256.2860 -6.77%
2023 234.7975 241.3680 275.3230 201.2850 274.9020 13.46%
2022 224.0643 202.7150 267.8800 197.7610 242.2810 20.43%
2021 203.6112 196.5840 226.4500 177.8460 201.1770 0.89%
2020 198.0202 202.6400 223.3020 154.8990 199.4120 -1.99%
2019 162.9521 157.1800 205.2560 138.3380 203.4590 27.60%
2018 151.9959 140.8370 170.5720 133.1230 159.4490 15.23%
2017 134.0879 116.6690 150.9450 116.6690 138.3710 22.27%
2016 119.2815 119.4240 135.0370 103.9730 113.1700 -7.57%
2015 118.1398 118.2250 131.9110 99.2415 122.4340 3.95%
2014 96.1089 83.9977 126.9130 80.7659 117.7810 42.33%
2013 74.7865 63.4899 85.7366 58.4548 82.7501 34.80%
2012 53.9376 44.7942 64.2163 44.5497 61.3890 36.83%
2011 38.8587 38.4141 45.2344 33.3798 44.8641 18.17%
2010 38.5533 39.9147 42.2797 34.8251 37.9646 -2.95%
2009 37.9750 40.7930 44.5410 31.1946 39.1195 -2.04%
2008 35.3652 32.2250 45.5645 27.6402 39.9355 24.35%
2007 40.0561 47.3002 52.4520 32.1143 32.1143 -32.02%
2006 48.8514 55.5708 55.5708 44.2022 47.2380 -13.38%
2005 48.3713 44.4511 59.5886 39.5551 54.5335 22.93%
2004 40.7310 43.1165 45.7996 36.4433 44.3612 3.82%
2003 42.4907 34.1059 49.4716 33.8017 42.7292 27.82%
2002 34.1556 39.0019 43.2064 21.4856 33.4282 -14.35%
2001 43.0917 43.4795 51.3024 35.6204 39.0296 -11.73%
2000 45.2732 43.5227 53.9388 35.4838 44.2143 6.45%
1999 25.6592 18.5631 44.8626 18.0877 41.5346 129.77%
1998 11.5528 9.3248 18.1309 8.1470 18.0768 93.19%
1997 9.6340 9.4436 11.8208 7.9417 9.3572 -0.46%
1996 10.1152 10.0703 11.3237 8.9034 9.4004 -8.42%
1995 7.0466 5.0352 10.2648 4.8839 10.2648 101.27%
1994 4.1853 4.2464 5.1324 3.0565 5.1000 19.19%
1993 3.6349 6.1048 6.1157 2.7229 4.2788 -29.91%
1992 5.5746 6.4615 6.7208 4.3220 6.1048 -6.77%
1991 3.9052 1.8369 6.5479 1.6640 6.5479 265.05%
1990 1.1382 0.7419 1.8260 0.6447 1.7937 154.10%
1989 0.6318 0.4610 0.8644 0.4592 0.7059 45.19%
1988 0.4406 0.4646 0.5150 0.3710 0.4862 8.87%
1987 0.4645 0.3404 0.6411 0.2341 0.4466 40.93%
1986 0.2914 0.1819 0.4088 0.1801 0.3169 62.93%
1985 0.1105 0.0685 0.2089 0.0667 0.1945 169.76%
1984 0.0791 0.1044 0.1189 0.0522 0.0721 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $155.172B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $228.104B 16.64
Gilead Sciences (GILD) United States $148.165B 15.43
Vertex Pharmaceuticals (VRTX) United States $93.977B 24.23
Bristol Myers Squibb (BMY) United States $93.528B 6.83
CSL (CSLLY) Australia $82.703B 0.00
GSK (GSK) United Kingdom $77.081B 8.96
Regeneron Pharmaceuticals (REGN) United States $59.671B 14.52
Alnylam Pharmaceuticals (ALNY) United States $57.535B 0.00
Argenex SE (ARGX) Netherlands $40.504B 71.24
BioNTech SE (BNTX) Germany $26.843B 0.00
Insmed (INSM) United States $23.156B 0.00
Royalty Pharma (RPRX) United States $21.129B 8.56
Biogen (BIIB) United States $19.158B 8.16
Incyte (INCY) United States $15.308B 19.50
Illumina (ILMN) United States $14.534B 22.73
Genmab (GNMSF) Denmark $14.293B 12.66
Genmab (GMAB) Denmark $13.748B 12.53
Ascendis Pharma (ASND) Denmark $11.710B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.008B 15.54
QIAGEN (QGEN) Netherlands $10.679B 20.48
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Moderna (MRNA) United States $10.163B 0.00
Exelixis (EXEL) United States $10.154B 18.31
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.963B 0.00
Bio-Techne Corp (TECH) United States $7.904B 29.15
Roivant Sciences (ROIV) United Kingdom $7.811B 0.00
Exact Sciences (EXAS) United States $7.760B 0.00
Halozyme Therapeutics (HALO) United States $7.751B 12.94
Anbio Biotechnology (NNNN) Germany $7.347B 0.00
Legend Biotech (LEGN) United States $6.799B 0.00
Guardant Health (GH) United States $6.763B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.751B 36.02
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Revolution Medicines (RVMD) United States $6.543B 0.00
Repligen (RGEN) United States $6.269B 68.36
Rhythm Pharmaceuticals (RYTM) United States $6.109B 0.00
Avidity Biosciences (RNA) United States $5.955B 0.00
Nuvalent (NUVL) United States $5.322B 0.00
Abivax SA (ABVX) France $5.298B 0.00
Axsome Therapeutics (AXSM) United States $5.230B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.002B 0.00
Merus (MRUS) Netherlands $4.841B 0.00
Alkermes (ALKS) Ireland $4.409B 12.25
Viking Therapeutics (VKTX) United States $4.261B 0.00
TG Therapeutics (TGTX) United States $4.240B 72.19
ACADIA Pharmaceuticals (ACAD) United States $4.150B 38.44
Cytokinetics (CYTK) United States $4.082B 0.00
Akero Therapeutics (AKRO) United States $4.023B 0.00
Krystal Biotech (KRYS) United States $4.013B 28.18
ADMA Biologics Inc (ADMA) United States $3.944B 28.48
Ascentage Pharma Group - (AAPG) China $3.900B 0.00
Arcellx (ACLX) United States $3.885B 0.00
Zai Lab (ZLAB) China $3.883B 0.00
Vaxcyte (PCVX) United States $3.882B 0.00
Telix Pharmaceuticals (TLX) Australia $3.837B 0.00
PTC Therapeutics (PTCT) United States $3.605B 5.99
Zealand Pharma (ZLDPF) Denmark $3.561B 0.00
Jyong Biotech (MENS) Taiwan $3.446B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.354B 0.00
Metsera (MTSR) United States $3.194B 0.00
Protagonist Therapeutics (PTGX) United States $3.177B 72.96
Apellis Pharmaceuticals (APLS) United States $3.078B 0.00
Scholar Rock Holding (SRRK) United States $3.072B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.013B 0.00
Bavarian Nordic (BVNRY) Denmark $2.919B 15.43
Ligand Pharmaceuticals (LGND) United States $2.895B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.654B 0.00
Kymera Therapeutics (KYMR) United States $2.645B 0.00
Immunovant (IMVT) United States $2.645B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.616B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.565B 0.00
Alvotech (ALVO) Luxembourg $2.551B 14.59
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.383B 803.75
ImmunityBio (IBRX) United States $2.306B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.268B 0.00
Belite Bio (BLTE) United States $2.225B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.179B 0.00
Amicus Therapeutics (FOLD) United States $2.084B 0.00
Agios Pharmaceuticals (AGIO) United States $2.078B 0.00
Denali Therapeutics (DNLI) United States $2.028B 0.00
IDEAYA Biosciences (IDYA) United States $2.025B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.020B 0.00
Disc Medicine (IRON) United States $2.010B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.967B 11.03
Mesoblast (MESO) Australia $1.924B 0.00
CG Oncology (CGON) United States $1.894B 0.00
Adaptive Biotechnologies (ADPT) United States $1.858B 0.00
Vericel (VCEL) United States $1.829B 302.00
Celcuity (CELC) United States $1.785B 0.00
Beam Therapeutics (BEAM) United States $1.782B 0.00
Sarepta Therapeutics (SRPT) United States $1.781B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.771B 0.00
ANI Pharmaceuticals (ANIP) United States $1.765B 15.85
Certara (CERT) United States $1.757B 32.18
Liquidia Technologies (LQDA) United States $1.748B 0.00
Apogee Therapeutics (APGE) United States $1.630B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.606B 0.00
Cidara Therapeutics (CDTX) United States $1.572B 0.00
Twist Bioscience (TWST) United States $1.548B 0.00
Travere Therapeutics (TVTX) United States $1.510B 0.00
Biohaven (BHVN) United States $1.505B 0.00
Celldex Therapeutics (CLDX) United States $1.372B 0.00
Janux Therapeutics (JANX) United States $1.372B 0.00
Novavax (NVAX) United States $1.359B 3.67
Viridian Therapeutics (VRDN) United States $1.340B 0.00
89BIO (ETNB) United States $1.338B 0.00
Edgewise Therapeutics (EWTX) United States $1.336B 0.00
WAVE Life Sciences (WVE) Singapore $1.287B 0.00
AbCellera Biologics (ABCL) Canada $1.270B 0.00
Vera Therapeutics (VERA) United States $1.262B 0.00
Cogent Biosciences (COGT) United States $1.248B 0.00
NovoCure (NVCR) Jersey $1.244B 0.00
Dynavax Technologies (DVAX) United States $1.240B 51.65
CureVac (CVAC) Germany $1.220B 5.91
GRAIL (GRAL) United States $1.181B 0.00
Pacira BioSciences (PCRX) United States $1.131B 11.99
Intellia Therapeutics (NTLA) United States $1.118B 0.00
MannKind (MNKD) United States $1.080B 32.00
Syndax Pharmaceuticals (SNDX) United States $1.075B 0.00
Pharvaris (PHVS) Netherlands $1.052B 0.00
MiMedx (MDXG) United States $1.039B 23.40
LENZ Therapeutics (LENZ) United States $0.989B 0.00
Praxis Precision Medicines (PRAX) United States $0.967B 0.00
Arcus Biosciences (RCUS) United States $0.964B 0.00
Anavex Life Sciences (AVXL) United States $0.946B 0.00
Structure Therapeutics (GPCR) United States $0.939B 0.00
Spyre Therapeutics (SYRE) United States $0.916B 0.00
Pharming Group (PHAR) Netherlands $0.906B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Trevi Therapeutics (TRVI) United States $0.870B 0.00
Upstream Bio (UPB) United States $0.863B 0.00
Mineralys Therapeutics (MLYS) United States $0.847B 0.00
Immunome (IMNM) United States $0.843B 0.00
Zymeworks (ZYME) United States $0.838B 0.00
Urogen Pharma (URGN) United States $0.821B 0.00
Geron (GERN) United States $0.817B 0.00
Oculis Holding AG (OCS) Switzerland $0.795B 0.00
Oric Pharmaceuticals (ORIC) United States $0.787B 0.00
Nuvation Bio (NUVB) United States $0.783B 0.00
Sionna Therapeutics (SION) United States $0.780B 0.00
Niagen Bioscience (NAGE) United States $0.776B 74.85
CorMedix Inc (CRMD) United States $0.771B 13.77
Pharming Group (PHGUF) Netherlands $0.765B 0.00
Iovance Biotherapeutics (IOVA) United States $0.764B 0.00
Nurix Therapeutics (NRIX) United States $0.752B 0.00
Immatics (IMTX) Germany $0.751B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.749B 0.00
NeoGenomics (NEO) United States $0.749B 0.00
BGM Group (BGM) China $0.749B 0.00
Tango Therapeutics (TNGX) United States $0.735B 0.00
UniQure (QURE) Netherlands $0.729B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.719B 0.00
Stoke Therapeutics (STOK) United States $0.715B 16.58
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.704B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.691B 0.00
Sana Biotechnology (SANA) United States $0.676B 0.00
Gyre Therapeutics (GYRE) United States $0.674B 179.75
Oxford BioMedica (OXBDF) United Kingdom $0.668B 0.00
Arbutus Biopharma (ABUS) United States $0.652B 0.00
GH Research (GHRS) Ireland $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
MeiraGTx Holdings (MGTX) United States $0.633B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.625B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.620B 0.00
ArriVent BioPharma (AVBP) United States $0.615B 0.00
Zenas BioPharma (ZBIO) United States $0.612B 0.00
Dianthus Therapeutics (DNTH) United States $0.603B 0.00
Fortrea Holdings (FTRE) United States $0.597B 10.61
Vir Biotechnology (VIR) United States $0.597B 0.00
AnaptysBio (ANAB) United States $0.589B 0.00
Myriad Genetics (MYGN) United States $0.588B 0.00
Maze Therapeutics (MAZE) United States $0.575B 0.00
Castle Biosciences (CSTL) United States $0.562B 55.31
Keros Therapeutics (KROS) United States $0.558B 44.29
Bicara Therapeutics (BCAX) United States $0.556B 0.00
Tyra Biosciences (TYRA) United States $0.555B 0.00
Terns Pharmaceuticals (TERN) United States $0.532B 0.00
Rapport Therapeutics (RAPP) United States $0.531B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.530B 0.00
Precigen (PGEN) United States $0.525B 0.00
Opthea (OPT) Australia $0.525B 0.00
Septerna (SEPN) United States $0.521B 0.00
ATyr Pharma (ATYR) United States $0.519B 0.00
Cytek Biosciences (CTKB) United States $0.513B 0.00
Prime Medicine (PRME) United States $0.509B 0.00
Rezolute (RZLT) United States $0.505B 0.00
Solid Biosciences (SLDB) United States $0.488B 0.00
Kura Oncology (KURA) United States $0.481B 0.00
Arvinas (ARVN) United States $0.462B 0.00
Eton Pharmaceuticals (ETON) United States $0.460B 0.00
Emergent Biosolutions (EBS) United States $0.457B 3.74
Palvella Therapeutics (PVLA) United States $0.452B 0.00
ITeos Therapeutics (ITOS) United States $0.447B 0.00
Cullinan Therapeutics (CGEM) United States $0.431B 0.00
Kodiak Sciences (KOD) United States $0.417B 0.00
Tectonic Therapeutic (TECX) United States $0.417B 0.00
PureTech Health (PRTC) United States $0.416B 0.00
Verastem (VSTM) United States $0.415B 0.00
Prothena (PRTA) Ireland $0.414B 0.00
Replimune (REPL) United States $0.413B 0.00
Kamada (KMDA) Israel $0.409B 24.55
MBX Biosciences (MBX) United States $0.409B 0.00
Gossamer Bio (GOSS) United States $0.400B 0.00
Erasca (ERAS) United States $0.397B 0.00
REGENXBIO (RGNX) United States $0.397B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.392B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.385B 0.00
Humacyte (HUMA) United States $0.385B 0.00
Compass Therapeutics (CMPX) United States $0.373B 0.00
Northwest Biotherapeutics (NWBO) United States $0.367B 0.00
Absci (ABSI) United States $0.362B 0.00
Astria Therapeutics (ATXS) United States $0.354B 0.00
Fulcrum Therapeutics (FULC) United States $0.351B 0.00
Inventiva S.A (IVA) France $0.342B 0.00
Aura Biosciences (AURA) United States $0.342B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.323B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.321B 0.00
Abeona Therapeutics (ABEO) United States $0.320B 0.00
Olema Pharmaceuticals (OLMA) United States $0.317B 0.00
XOMA Royalty (XOMA) United States $0.317B 0.00
Amarin (AMRN) Ireland $0.310B 0.00
Benitec Biopharma (BNTC) United States $0.310B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.309B 0.00
Inhibrx Biosciences (INBX) United States $0.305B 0.18
Neurogene (NGNE) United States $0.303B 0.00
Candel Therapeutics (CADL) United States $0.302B 0.00
Ocugen (OCGN) United States $0.292B 0.00
I-Mab (IMAB) United States $0.278B 0.00
Cartesian Therapeutics (RNAC) United States $0.274B 0.00
Bright Minds Biosciences (DRUG) United States $0.273B 0.00
Lifecore Biomedical (LFCR) United States $0.271B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.271B 12.17
DBV Technologies S.A (DBVT) France $0.269B 0.00
Atea Pharmaceuticals (AVIR) United States $0.268B 0.00
Sagimet Biosciences (SGMT) United States $0.268B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.266B 0.00
Prima BioMed (IMMP) Australia $0.263B 0.00
Vor Biopharma (VOR) $0.262B 0.00
Aardvark Therapeutics (AARD) United States $0.260B 0.00
Annexon (ANNX) United States $0.259B 0.00
Foghorn Therapeutics (FHTX) United States $0.259B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.257B 0.00
Crescent Biopharma (CBIO) United States $0.251B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.248B 0.00
ScPharmaceuticals (SCPH) United States $0.247B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.246B 0.00
Design Therapeutics (DSGN) United States $0.244B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.243B 0.00
DiaMedica Therapeutics (DMAC) United States $0.241B 0.00
Neumora Therapeutics (NMRA) United States $0.236B 0.00
Alumis (ALMS) United States $0.234B 0.00
Adherex Technologies (FENC) United States $0.232B 0.00
Codexis (CDXS) United States $0.229B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.228B 0.00
Allogene Therapeutics (ALLO) United States $0.227B 0.00
Alpha Teknova (TKNO) United States $0.226B 0.00
Tvardi Therapeutics (TVRD) United States $0.224B 0.00
Alector (ALEC) United States $0.218B 0.00
CARGO Therapeutics (CRGX) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
AC Immune (ACIU) Switzerland $0.215B 0.00
Monopar Therapeutics (MNPR) United States $0.212B 0.00
Ventyx Biosciences (VTYX) United States $0.200B 0.00
Entrada Therapeutics (TRDA) United States $0.197B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
CytomX Therapeutics (CTMX) United States $0.189B 4.20
Eupraxia Pharmaceuticals (EPRX) Canada $0.189B 0.00
EnGene Holdings (ENGN) Canada $0.188B 0.00
Puma Biotechnology (PBYI) United States $0.186B 3.77
Editas Medicine (EDIT) United States $0.185B 0.00
Instil Bio (TIL) United States $0.184B 0.00
C4 Therapeutics (CCCC) United States $0.178B 0.00
Voyager Therapeutics (VYGR) United States $0.174B 0.00
BioStem Technologies (BSEM) $0.173B 7.04
Cuprina Holdings (Cayman) (CUPR) Singapore $0.172B 0.00
Contineum Therapeutics (CTNM) United States $0.167B 0.00
Semper Paratus Acquisition (TVGN) United States $0.166B 0.00
Actuate Therapeutics (ACTU) United States $0.164B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.163B 0.00
Rapt Therapeutics (RAPT) United States $0.162B 0.00
Caribou Biosciences (CRBU) United States $0.161B 0.00
Cardiff Oncology (CRDF) United States $0.159B 0.00
Alpha Cognition (ACOG) Canada $0.159B 0.00
SELLAS Life Sciences (SLS) United States $0.158B 0.00
BioAge Labs (BIOA) United States $0.155B 0.00
Nuvectis Pharma (NVCT) United States $0.153B 0.00
Elicio Therapeutics (ELTX) United States $0.150B 0.00
Molecular Partners AG (MOLN) Switzerland $0.148B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.148B 0.00
MaxCyte (MXCT) United States $0.147B 0.00
Theratechnologies (THTX) Canada $0.147B 0.00
Cellectis S.A (CLLS) France $0.145B 0.00
BioHarvest Sciences (BHST) Canada $0.144B 0.00
Citius Oncology (CTOR) United States $0.142B 0.00
Nkarta (NKTX) United States $0.141B 0.00
Kyverna Therapeutics (KYTX) United States $0.140B 0.00
Black Diamond Therapeutics (BDTX) United States $0.137B 10.44
Seer (SEER) United States $0.135B 0.00
Compugen (CGEN) Israel $0.134B 0.00
Agenus (AGEN) United States $0.132B 0.00
Seres Therapeutics (MCRB) United States $0.124B 0.00
OKYO Pharma (OKYO) $0.123B 0.00
Spero Therapeutics (SPRO) United States $0.122B 0.00
IO Biotech (IOBT) Denmark $0.119B 0.00
Genelux (GNLX) United States $0.119B 0.00
Immuneering (IMRX) United States $0.117B 0.00
Anika Therapeutics (ANIK) United States $0.117B 0.00
Connect Biopharma Holdings (CNTB) United States $0.115B 0.00
Climb Bio (CLYM) United States $0.115B 0.00
23andMe Holding (MEHCQ) United States $0.110B 0.00
Scilex Holding (SCLX) United States $0.109B 0.00
Skye Bioscience (SKYE) United States $0.109B 0.00
Tenaya Therapeutics (TNYA) United States $0.109B 0.00
Sangamo Therapeutics (SGMO) United States $0.107B 0.00
Fate Therapeutics (FATE) United States $0.106B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.104B 0.00
HilleVax (HLVX) United States $0.104B 0.00
Adagene (ADAG) China $0.102B 0.00
Pliant Therapeutics (PLRX) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
TuHURA Biosciences (HURA) United States $0.100B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.099B 0.00
Zura Bio (ZURA) United States $0.097B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
Invivyd (IVVD) United States $0.096B 0.00
Coherus Oncology (CHRS) United States $0.095B 0.00
TScan Therapeutics (TCRX) United States $0.093B 0.00
Nautilus Biotechnology (NAUT) United States $0.092B 0.00
VistaGen Therapeutics (VTGN) United States $0.091B 0.00
XBiotech (XBIT) United States $0.089B 0.00
Quince Therapeutics (QNCX) United States $0.088B 0.00
Immunic (IMUX) United States $0.086B 0.00
CervoMed (CRVO) United States $0.086B 0.00
Quantum Biopharma (QNTM) Canada $0.085B 0.00
Oncolytics Biotech (ONCY) Canada $0.084B 0.00
Alto Neuroscience (ANRO) United States $0.083B 0.00
Entera Bio (ENTX) Israel $0.083B 0.00
Elutia (ELUT) United States $0.083B 0.00
Whitehawk Therapeutics (WHWK) United States $0.082B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.082B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
BeyondSpring (BYSI) United States $0.081B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.080B 0.00
Celularity (CELU) United States $0.078B 0.00
IGM Biosciences (IGMS) United States $0.077B 0.00
Cabaletta Bio (CABA) United States $0.069B 0.00
INmune Bio (INMB) United States $0.068B 0.00
TELA Bio (TELA) United States $0.068B 0.00
Sutro Biopharma (STRO) United States $0.068B 0.00
Genenta Science S.p.A (GNTA) Italy $0.068B 0.00
Artiva Biotherapeutics (ARTV) United States $0.067B 0.00
Forte Biosciences (FBRX) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Atara Biotherapeutics (ATRA) United States $0.065B 0.00
Opus Genetics (IRD) United States $0.064B 0.00
Oncobiologics (OTLK) United States $0.064B 0.00
Cue Biopharma (CUE) United States $0.063B 0.00
Applied Therapeutics (APLT) United States $0.060B 0.00
ImageneBio (IMA) United States $0.059B 0.00
Biomea Fusion (BMEA) United States $0.058B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
Cognition Therapeutics (CGTX) United States $0.055B 0.00
ZIVO Bioscience (ZIVO) United States $0.055B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Lantern Pharma (LTRN) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.052B 0.00
Adicet Bio (ACET) United States $0.051B 0.00
PDS Biotechnology (PDSB) United States $0.051B 0.00
Kalaris Therapeutics (KLRS) United States $0.050B 0.00
Annovis Bio (ANVS) United States $0.050B 0.00
MiNK Therapeutics (INKT) United States $0.048B 0.00
Alterity Therapeutics - (ATHE) Australia $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.048B 0.00
KALA BIO (KALA) United States $0.048B 0.00
Exicure (XCUR) United States $0.047B 0.00
Aligos Therapeutics (ALGS) United States $0.047B 0.00
ABVC BioPharma (ABVC) United States $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
Grace Therapeutics (GRCE) Canada $0.045B 0.00
Renovaro (RENB) United States $0.042B 0.00
RenovoRx (RNXT) United States $0.042B 0.00
Senti Biosciences (SNTI) United States $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.039B 0.00
CalciMedica (CALC) United States $0.038B 0.00
Pluri (PLUR) Israel $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Jasper Therapeutics (JSPR) United States $0.037B 0.00
Ovid Therapeutics (OVID) United States $0.037B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.036B 0.00
Shattuck Labs (STTK) United States $0.036B 0.00
ALX Oncology Holdings (ALXO) United States $0.036B 0.00
PepGen (PEPG) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
Rani Therapeutics Holdings (RANI) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
Mersana Therapeutics (MRSN) United States $0.031B 0.00
Clene (CLNN) United States $0.030B 0.00
Estrella Immunopharma (ESLA) United States $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
CAMP4 Therapeutics (CAMP) United States $0.029B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Generation Bio (GBIO) United States $0.028B 0.00
OnKure Therapeutics (OKUR) United States $0.028B 0.00
Medicus Pharma (MDCX) United States $0.027B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.026B 0.00
Rein Therapeutics (RNTX) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
BioXcel Therapeutics (BTAI) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
Cadrenal Therapeutics (CVKD) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Rallybio (RLYB) United States $0.022B 0.00
Cingulate (CING) United States $0.022B 0.00
Curis (CRIS) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.021B 0.00
Moleculin Biotech (MBRX) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Promis Neurosciences (PMN) Canada $0.018B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
180 Life Sciences (ATNF) United States $0.018B 0.00
Equillium (EQ) United States $0.018B 0.00
Imunon (IMNN) United States $0.018B 0.00
Dare Bioscience (DARE) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
LakeShore Biopharma (LSB) China $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Longeveron (LGVN) United States $0.010B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Portage Biotech (PRTG) $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.009B 0.00
Synaptogenix (TAOX) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Artelo Biosciences (ARTL) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00